geneOmbio’s Molecular diagnostic services has initiated a promotional drive for its Hepatitis C Virus genotyping assay due to growing importance of this test. Hepatitis C virus (HCV) is an important and widely transmitted virus in the world. Estimates from the World...

The new era of Hepatitis C management is marked by newly available tests for IL28B polymorphisms, US Food and Drug Administration (FDA) approval of the first direct acting antivirals (DAA; boceprevir and telaprevir), monitoring of drug-related mutations. With the...

Last year we saw many developmental activities through geneOmbio’s R&D effort that are now getting translated into active business through new cases being prescribed for testing in pharmacogenomics domain. We have recently come up analysis of a different gene in...

geneOmbio technologies has been working on development and offering various oncology related tests having prognostic value as well as pharmacogenetic significance. Recently we have worked on development of an important test for Breast cancer. Breast cancer is the most...